Oncologic applications of diffusion-weighted MRI in the body

109Citations
Citations of this article
117Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Diffusion-weighted MRI (DWI) allows the detection of malignancies in the abdomen and pelvis. Lesion detection and characterization using DWI largely depends on the increased cellularity of solid or cystic lesions compared with the surrounding tissue. This increased cellularity leads results in restricted diffusion as indicated by reduction in the apparent diffusion coefficient (ADC). Low pretreatment ADC values of several malignancies have been shown to be predictive of better outcome. DWI can assess response to systemic or regional treatment of cancer at a cellular level and will therefore detect successful treatment earlier than anatomical measures. In this review, we provide a brief technical overview of DWI, discuss quantitative image analysis approaches, and review studies which have used DWI for the purpose of detection and characterization of malignancies as well as the early prediction of treatment response. © 2011 Wiley Periodicals, Inc.

Cite

CITATION STYLE

APA

Bonekamp, S., Corona-Villalobos, C. P., & Kamel, I. R. (2012, February 1). Oncologic applications of diffusion-weighted MRI in the body. Journal of Magnetic Resonance Imaging. John Wiley and Sons Inc. https://doi.org/10.1002/jmri.22786

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free